BioCentury
ARTICLE | Financial News

Adolor up on Entereg results

February 9, 2006 3:10 AM UTC

On Wednesday, ADLR gained $6.53 (41%) to $22.29 on 7.2 million shares after announcing late Tuesday that Entereg alvimopan met the primary endpoint of time to recovery of gastrointestinal function (GI...